Experimental drug cocktail tested to fight returning blood cancer
NCT ID NCT03361306
Summary
This study tested a new combination of four drugs for people whose multiple myeloma had returned or stopped responding to one prior treatment. The goal was to see if this four-drug mix could reduce the amount of cancer in the body. After an initial intensive treatment phase, patients continued on a lower-dose maintenance therapy to try to keep the cancer under control for as long as possible.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Levine Cancer Institute
Charlotte, North Carolina, 28204, United States
Conditions
Explore the condition pages connected to this study.